Evaluating access to Malaria Rapid Diagnostic Test kit and Artemisinin-based Combination Therapy and the Quality of Treatment Practice among Over-the-Counter Medicine Sellers at the District Level in the Brong Ahafo Region - Ghana
Abstract:
Background: Accurate
diagnosis and appropriate treatment of malaria with the recommended antimalarials
are crucial in the fight against malaria. This study evaluated the availability
and sources of ACT and RDT kits among the Over-The-Counter (OTC) medicine
sellers in the Pru, Sene and Atebubu-Amantin Districts of Ghana.
Method: A
cross-sectional descriptive study was conducted using a structured
questionnaire. Sixty-two OTC medicine sellers were randomly selected, informed
consent sought and interviewed on access to RDT kit, ACT and Training in
malaria diagnosis. Data entry, editing and analysis was done using SPSS Ver 22.
Results: The study
revealed that 26.2% of respondents use the RDT kits to diagnosis and confirm
suspected malaria. 94.1% respondents who had malaria RDT kits at their shop
purchased them from the NMCP and Pharmacy shops. 95% of respondents had in
stock at least one of the 3 recommended ACT - artesunate amodiaquine,
artemether lumefantrine, and/or dihydroartemisinin piperaquine.65.6% of
respondents often recommend artemether lumefantrine to patients to treat
uncomplicated malaria.. The average wholesale and retail prices of the
Affordable Medicine Facility malaria (AMFm) branded ACT were higher than the
approved suggested retail prices.
Conclusion: Most OTC
medicine sellers do not comply with the national antimalarial drug treatment
policy. 85% of OTC medicine sellers purchase their AMFm branded ACT from
second-line buyers at relatively higher price.
Recommendation: Regular
training of OTC medicine sellers on malaria control and easier access to
quality and affordable malaria RDT kits and ACT would help improve malaria
control at the community level.
Keywords: Malaria,
ACT, RDT, OTC medicine seller, Pru, Sene and Atebubu-Amantin.
References:
[1]. Affordable Medicine Facility-malaria
(AMFm) first-line buyers list, Global Fund, September, 2013.
[2]. Ahorlu CK, Dunyo SK, Afari EA, Koram
KA, Nkrumah FK: Malaria-related beliefs and behaviour in southern Ghana:
implications for treatment, prevention and control. Trop Med Int Health 2:
488–499,1997
[3]. Ansah E.K, Narh-Bana.S ,
Affran-Bonful H, Bart-Plange C, Cundill B., Gyapong M, Whitty C. J .M, The
impact of providing rapid diagnostic malaria tests on fever management in the
private retail sector in Ghana: a cluster randomized trial, BMJ 2015;350:h1019
doi: 10.1136/bmj.h1019 (Published 4 March 2015)
[4]. Arrow KJ, Panosian CB, Gelband H.
Saving lives, buying time: economics of malaria drugs in an age of resistance. Institute
of Medicine, 2004
[5]. Buabeng K.O, The Role of the
Pharmaceutical Sector in malaria Control in Ghana, Faculty of Health Science,
University of Eastern Finland 2010
[6].
Cohen JC, Gyansa-Lutterodt M, Torpey
K, Esmail LC, Kurokawa G: TRIPS, the Doha Declaration and increasing access to
medicines: policy options for Ghana. Global Health 1: 17, 2005
[7]. Danquah D.A ,Evaluating Access to
Anti-Malaria medicine and quality of Service delivery by Community Pharmacies
and Licensed Chemical Shops in Ashanti Region, Ghana 2010
[8]. FHI 360, OTC medicine sellers
identification and selection exercise, Pru, Sene and Atebubu-Amantin districts,
2015, Ghana
[9]. Gallup, JL; Sachs, JD. The economic
burden of malaria. Am J Trop Med Hyg. 2001; 64:85–96. [PubMed]
[10]. Ghana
district map -www.ghanadistricts.com/home) accessed on May 5th, 2015
[11]. Global
Fund AMFm pricing , August 2010 report
[12]. Goodman
C, Brieger W, Unwin A, Mills A, Meek S, Greer G: Medicine sellers and malaria
treatment in sub-Saharan Africa: what do they do and how can their practice be
improved? Am J Trop Med Hyg 77(Suppl 6): 203–218, 2007a
[13]. Health Partners Ghana. Management of
malaria by care givers and licensed chemical sellers in the Ashanti Region,
Ghana. A baseline survey of the MAM Project October, 2008.
[14]. Ministry of Health (GNDP) Ghana: Ghana
national drug policy, second edition 2004. Accessed May 4th 2015 from http://who.int/countries/gha/publications/Ghana_National_DrugPolicy_2nd_Edition.pdf
[15]. Pharmacy Council, Ghana: Practice standards
for pharmacist and licensed chemical sellers, 2004.
[16]. Republic of Ghana (Pharmacy ACT 489):
Pharmacy Council ACT, 1994
[17]. World Health Organization: Guidelines for
Treatment of Malaria, 2015
[18]. World Health Organization: World Malaria
Report 2015.
[19]. WHO The Roll Back Malaria strategy for improving access to treatment through home management of malaria. World Health Organization. 2005.